44 |
Novel HDL Targeted Therapies: The Search Continues, ... |
Karam Maximilian Kostner |
Jul. 04. 08 |
43 |
Torcetrapib's Failure: Find More Stories in the ILLUMINATE Trial |
Mats Eriksson |
Jul. 04. 08 |
42 |
Cutting-Edge Lipid Therapy, Clinical Updates |
Ki Hoon Han |
Jul. 04. 08 |
41 |
Regression: An Evidence-Based Assessment |
Cheol Whan Lee |
Jul. 04. 08 |
40 |
Biochemical Surrogate: Is It Valuable for Risk Stratification? |
James Kuang-Jan Liao |
Jul. 04. 08 |
39 |
In-Depth Review of CV Outcomes Through Statin Treatment Based on ALPS |
Dong-Ju Choi |
Nov. 23. 07 |
38 |
Emerging Type 2 Diabetes Therapies: Potential of the New DPP-4 Inhibitors |
Ki Hoon Han |
Nov. 23. 07 |
37 |
Role of Statin: Optimal Treatment for PCI Patients |
Sang-Hak Lee |
Nov. 23. 07 |
36 |
The Road to Renin System Optimization; From ARB to Direct Renin Inhibition |
Yong-Jin Kim |
Nov. 23. 07 |
35 |
Achieving the Superior Treatment Goal for Patients at Risks Through Powerful Inhibition of Two Sources of Cholesterol -"VYTAL Study" |
Szilard Voros |
Nov. 09. 07 |